Dr. Howe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Providence VA Medical Center
830 Chalkstone Ave
Providence, RI 02908
Education & Training
Butler Hospital/Brown UniversityResidency, Psychiatry, 2020 - 2024
McGovern Medical School at UTHealthClass of 2020
Certifications & Licensure
RI State Medical License 2020 - 2026
Publications & Presentations
PubMed
- Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis.Matthew D Howe, Megan R Caruso, Masood Manoochehri, Zachary J Kunicki, Sheina Emrani
Alzheimer's & Dementia. 2024-10-01 - Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease.Matthew D Howe, Karysa J Britton, Hannah E Joyce, William Menard, Sheina Emrani
Alzheimer's Research & Therapy. 2024-07-06 - 1 citationsReal-World Application of Anti-β-Amyloid Monoclonal Antibodies: Untangling Eligibility.Matthew D Howe, Gil D Rabinovici, Stephen P Salloway
Neurology. 2023-11-07
Press Mentions
Is ARIA an Inflammatory Reaction to Vascular Amyloid?August 11th, 2023- Most with Early AD Not Eligible for New Anti-Amyloid DrugsAugust 18th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
